FIELD: biotechnology.
SUBSTANCE: disclosed are a culture medium and a method for culturing rapidly multiplying primary cells of oesophageal squamous cell carcinoma in vitro, and their use for drug screening. Culture medium contains an initial culture medium selected from DMEM/F12, DMEM, F12 or RPMI-1640, a Rho protease inhibitor, an antibiotic, insulin, excipient N2, insulin-like growth factor 1, non-essential amino acid, hydrocortisone, glutamine, and bovine pituitary extract.
EFFECT: disclosed are a culture medium for primary cells of oesophageal squamous cell carcinoma and a method for culturing said cells.
6 cl, 11 dwg, 7 tbl, 9 ex
| Title | Year | Author | Number |
|---|---|---|---|
| CULTURE MEDIUM FOR EPITHELIAL CELLS OF ESOPHAGEAL SQUAMOUS CELL CARCINOMA, METHOD OF CULTIVATION AND USE THEREOF | 2020 |
|
RU2816529C1 |
| CULTURE MEDIUM FOR EPITHELIAL CELLS OF LARYNGEAL CANCER, METHOD OF CULTIVATION AND USE THEREOF | 2020 |
|
RU2814719C1 |
| CULTURE MEDIUM FOR PRIMARY EPITHELIAL CELLS OF MAMMARY GLAND, METHOD OF CULTIVATION AND USE THEREOF | 2019 |
|
RU2819362C1 |
| COMPOSITION OF THE CULTURE MEDIUM AND METHOD OF CULTURING OF THE CELL OR TISSUE USING THE SPECIFIED COMPOSITION | 2013 |
|
RU2665793C2 |
| CULTURE MEDIUM FOR EPITHELIAL STEM CELLS AND ORGANOIDS, CONTAINING THEREOF | 2010 |
|
RU2555545C2 |
| CULTURE MEDIUM FOR STEM CELLS | 2012 |
|
RU2714256C2 |
| METHOD FOR PROLIFERATION OF LAK CELLS | 2007 |
|
RU2462511C2 |
| USE OF SESQUITERPENE LACTONE COMPOUND IN PREPARING DRUGS FOR RELIEVING RADIATION-INDUCED INJURIES | 2021 |
|
RU2822760C1 |
| COMBINATION OF A HISTONE DEACETYLASE INHIBITOR AND A PROTEIN KINASE INHIBITOR AND PHARMACEUTICAL APPLICATION THEREOF | 2019 |
|
RU2770754C1 |
| HUMAN UTERINE CERVICAL STEM CELL POPULATION AND USES THEREOF | 2014 |
|
RU2679500C2 |
